cRGD-modification helped miR497 and triptolide (TP) release in the acidic tumor, which upregulated the polarization of macrophages from M2 to M1 macrophages by inhibiting the PI3K/AKT/mTOR signaling pathway (Li Z T et al., 2022). The gene discussed is MTOR; the disease is neoplasm.